CWG
TVRD

C WorldWide Group’s Tvardi Therapeutics TVRD Stock Holding History

C WorldWide Group’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,207
Closed -$980K – 88
2023
Q3 		$980K Hold
16,207
– – 0.01% 81
2023
Q2 		$1.65M Hold
16,207
– – 0.02% 77
2023
Q1 		$2.87M Hold
16,207
– – 0.04% 71
2022
Q4 		$6.27M Hold
16,207
– – 0.08% 54
2022
Q3 		$5.46M Hold
16,207
– – 0.08% 54
2022
Q2 		$5.33M Hold
16,207
– – 0.07% 60
2022
Q1 		$7.09M Hold
16,207
– – 0.08% 53
2021
Q4 		$7.11M Hold
16,207
– – 0.07% 59
2021
Q3 		$9.01M Hold
16,207
– – 0.09% 50
2021
Q2 		$8.33M Sell
16,207
-3,334
-17% -$2.11M 0.09% 49
2021
Q1 		$15.3M Hold
19,541
– – 0.15% 49
2020
Q4 		$10.6M Hold
19,541
– – 0.11% 54
2020
Q3 		$8.95M Hold
19,541
– – 0.1% 53
2020
Q2 		$12M Hold
19,541
– – 0.14% 48
2020
Q1 		$9.29M Hold
19,541
– – 0.13% 45
2019
Q4 		$11.3M Hold
19,541
– – 0.14% 46
2019
Q3 		$12.9M Hold
19,541
– – 0.16% 38
2019
Q2 		$15.1M Buy
19,541
+15,556
+390% +$10.9M 0.19% 36
2019
Q1 		$2.81M Sell
3,985
-271
-6% -$162K 0.04% 79
2018
Q4 		$1.99M Sell
4,256
-2,617
-38% -$1.69M 0.03% 79
2018
Q3 		$5.93M Sell
6,873
-1,181
-15% -$853K 0.08% 58
2018
Q2 		$5.55M Buy
8,054
+1,616
+25% +$821K 0.08% 61
2018
Q1 		$2.87M Sell
6,438
-990
-13% -$480K 0.04% 74
2017
Q4 		$3.27M Sell
7,428
-665
-8% -$303K 0.05% 70
2017
Q3 		$3.99M Buy
8,093
+3,509
+77% +$1.76M 0.06% 73
2017
Q2 		$2.54M Sell
4,584
-1,377
-23% -$874K 0.04% 88
2017
Q1 		$3.95M Sell
5,961
-2,923
-33% -$1.56M 0.07% 64
2016
Q4 		$2.97M Buy
8,884
+1,440
+19% +$462K 0.06% 64
2016
Q3 		$2.24M Hold
7,444
– – 0.04% 86
2016
Q2 		$1.29M Buy
7,444
+166
+2% +$36.1K 0.02% 89
2016
Q1 		$1.63M Hold
7,278
– – 0.03% 81
2015
Q4 		$4.42M Sell
7,278
-2,113
-23% -$1.16M 0.08% 59
2015
Q3 		$4.83M Buy
9,391
+1,423
+18% +$953K 0.08% 53
2015
Q2 		$3.48M Buy
7,968
+222
+3% +$85.8K 0.05% 77
2015
Q1 		$2.8M Buy
7,746
+1,862
+32% +$705K 0.04% 75
2014
Q4 		$2.11M Buy
5,884
+290
+5% +$93.4K 0.03% 74
2014
Q3 		$1.67M Buy
+5,594
New +$2.3M 0.02% 83

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

C WorldWide Group's TVRD Position: Q4 2023 in Review

C WorldWide Group sold out of Tvardi Therapeutics (TVRD) in Q4 2023, closing a stake of 16,207 shares — an estimated $980K sold.

C WorldWide Group first reported a position in TVRD in Q3 2014 and held it in 37 quarters. The position peaked at $15.3M in Q1 2021. 109 funds tracked by Wall St. Rank hold TVRD as of Q4 2023.

  • C WorldWide Group reported no remaining Tvardi Therapeutics position as of Q4 2023 after selling out during the quarter.
  • C WorldWide Group sold 16,207 Tvardi Therapeutics shares in Q4 2023, an estimated $980K.
  • C WorldWide Group first reported a position in Tvardi Therapeutics in Q3 2014 and held it in 37 quarters.
  • C WorldWide Group's Tvardi Therapeutics position peaked at $15.3M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2023.

Based on C WorldWide Group's 13F filing for Q4 2023, filed 5 Feb 2024.